Skip to main content

Diabetes Mellitus: Pharmacotherapy- SGLT, Centrally Acting Dopamine Agonists & Bile Acid Sequestrants!

 PHARMACOTHERAPY:

Medications classifications include:

  1.  Sulfonyl Urea's
  2. Nonsylfonylurea Secretagogues (a-Glinides)
  3. Biguanides
  4. Thiazolidinediones
  5. a-Glucosidase Inhibitors
  6. Dipeptidyl Peptidase-4 Inhibitors (Gliptins)
  7. Sodium-glucose co-transporter (SGLT) Inhibitors 
  8. Central-Acting Dopamine Agonists
  9. Bile Acid Sequestrants
  10. Insulin therapy

7.SODIUM-GLUCOSE CO-TRANPORTER (SGLT-2) INHIBITORS

The drugs approved include Canagliflozin, Dapagliflozin, Empagliflozin.

Mechanism of Action:

  • Glucose is freely filtered buy the kidney glomeruli and is reabsorbed in the proximal convoluted tubules by the action of sodium glucose co-transporters (SGLT). SGLT accounts for 90% of the glucose reabsorption and its inhibition causes glycosuria in people with diabetes, lowering plasma glucose levels.

Dose:

Canagliflozin: 100 & 300mg- 100mg daily if usual dose. 300mg daily can be used if eGFR resulting in lowering HDL. 

Dapagliflozin: 3 & 10mg- 10 mg daily. 3mg daily in hepatic failure.

Empagliflozin: 10 & 25mg- 10mg daily. 25 mg daily can be used if necessary.


8.CENTRAL ACTING DOPAMINE AGONISTS

  • A quick release formulation of a central acting dopamine agonist Bromocriptine was approved by the FDA in May 2009 for the treatment of T2DM.

Mechanism of Action:

  • The exact mechanism of action of how bromocriptine regulates glycemic control is unknown, however, data indicates that bromocriptine administered in the morning improves insulin sensitivity and this is a likely result of its effect on dopamine oscillations.

Clinical use:

  • A modest A1c reduction of 0.1%-0.4% is expected from this drug.

Adverse Effects:

  • Rhinitis
  • Dizziness
  • Asthenia
  • Headache
  • Sinusitis
  • Constipation
  • Nausea

Dose:

  • When used to treat patients with T2DM, bromocriptine should be taken 2hr after waking up in the morning with food. 
  • The initial dose is 0.8mg, titrated up weekly until a maximum dosage of 4.8mg/day is achieved.

Contraindication:

  • It is contraindicated in patients with migraine and in women who are nursing.


9.BILE ACID SEQUESTRANTS

  • Colesevelam is the only bile acid sequestrant currently approved as the adjunctive therapy to improve glycemic control in conjunction with diet, exercise and insulin or oral agents for the treatment of T2 DM.

Mechanism of action:

It acts on the intestinal lumen to bind bile acid but whether this is the drugs only action that results in plasma glucose lowering or if a secondary systemic effect to bile acid binding is unknown.

Clinical use:

  • An A1c reduction of approximately 0.4% can be expected when added to metformin, sulfonylurea or insulin. 
  • FPG is reduced about 5-10mg/dL.
  • LDL cholesterol is reduced 12-16%

Dose:

  •   Dosing for T2DM is 6*625mg tablets daily which may be split into 3 tablets twice daily.

Adverse Effects:

  • Constipation
  • Dyspepsia
  • Drug-drug interactions with Levothyroxine, Glyburide, Oral contraceptives, Phenytoin, Warfarin, Digoxin
  • Malabsorption of fat-soluble vitamins A, D, E and K 

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more

Hospital Acquired Pneumonia- Definition, Predisposing Factors, Clinical Features and Management!

 HOSPITAL ACQUIRED PNEUMONIA Definition: "HAP refers to a new episode of pneumonia occurring at least 2 days after the administration to hospital. It is the most common Hospital Acquired Infection (HAI) and leading cause of HAI-associated death". Predisposing factors: Aspiration of nasopharyngeal secretion Bacteria introduced into the lower GIT. Bacteriaemia Old age Mode of Spread:  Droplet infection Infecting agent: Bacteria: S.pneumonia , S.aureus , H.influenza Virus: Adenovirus, Corona virus, Herpes Simplex Clinical Features: Purulent sputum New radiological infiltrates Temperature > 38 degree Celsius Leukocytosis Investigations: Chest Pain:  to confirm the diagnosis and exclude complication. Pulse Oximetry : to monitor response to oxygen therapy, if SaO2 < 93% features of sever pneumonia, identify ventilatory failure or acidosis. Cell count:  ESR, Neutrophil leukocytosis Microbiological studies:  for severe CAP and those that do not respond to ...
Post a Comment
Read more

Management of H.pylori and NSAID-associated ulcers Eradication!

MANAGEMENT FOR H.PYLORI ERADICATION It is known that H.pylori infection is associated with over 90% of duodenal ulcers and 80% of Gastric Ulcers. Antibiotics alone or acid-suppressing agents alone, do not eradicate H.pylori . Both therapies act synergistically as growth of the organism occurs at elevated pH and antibiotics efficacy is enhanced during growth. Additionally, increasing intragastric pH may enhance antibiotic absorption. High eradication rates are achieved by a short course of Triple Therapy consisting of:            1 .PPI                                         2. Clarithromycin                         3. Amoxicillin/Metronidazole          in a twice recommended simultaneous regimen. First-Line Therapy :  European Guidelines recommended 1 we...
Post a Comment
Read more